NCT03464786 is a NA clinical trial of Lando® absorbable collagen membrane in Tooth Extraction, sponsored by Shenzhen Lando Biomaterials Co., Ltd..

Who is sponsoring NCT03464786?

NCT03464786 is sponsored by Shenzhen Lando Biomaterials Co., Ltd..

What drugs are being tested in NCT03464786?

Interventions in NCT03464786: Lando® absorbable collagen membrane, Geistlich Bio-Gide resorbable bilayer membrane.

What condition does NCT03464786 study?

NCT03464786 studies Tooth Extraction.

Is NCT03464786 still recruiting?

NCT03464786 is currently completed. Last updated 11 September 2020.

Last reviewed 2020-09-11 · How we verify

NCT03464786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Study on the Efficacy and Safety of Lando® Absorbable Collagen Membrane in Oral Bone Repair

Completed NA Last updated 11 September 2020

What this trial tests

NA trial testing Lando® absorbable collagen membrane in Tooth Extraction in 119 participants. Completed in 5 September 2020.

Timeline

3 April 2018

Primary endpoint
5 September 2020

5 September 2020

Quick facts

Lead sponsor	Shenzhen Lando Biomaterials Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	119
Start date	3 April 2018
Primary completion	5 September 2020
Estimated completion	5 September 2020
Sites	1 location across China

Drugs / interventions tested

Lando® absorbable collagen membrane
Geistlich Bio-Gide resorbable bilayer membrane

Conditions studied

Tooth Extraction — all drugs for Tooth Extraction →

Sponsor

Shenzhen Lando Biomaterials Co., Ltd.

Who can join

Adults 18 to 65, any sex, with Tooth Extraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, paralleled, control trial to validate the effectiveness and safety of Lando® absorbable collagen membrane for oral bone repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tooth Extraction

Currently open trials in the same condition.

NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
NCT07154693 — Wound Healing Following Tooth Extraction and Ridge Preservation Using OsteoGen® · NA · recruiting
NCT06806241 — Effects of Tranexamic Acid Irrigation on Impacted Third Molar Surgery · recruiting
NCT07020767 — Effect of Two Incision Techniques on Soft and Hard Tissue Outcomes in Immediate Implant Placement in Class II Extraction · NA · active not recruiting
NCT06473922 — Assessing Levels of Fear and Anxiety and Monitoring Wound Healing Among Patients Who Are About to Undergo Wisdom Tooth E · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03464786 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shenzhen Lando Biomaterials Co., Ltd.
Last refreshed: 11 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03464786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing